Loading organizations...
Key people at SCVC.
SCVC was founded in 2020 by Harry Destecroix (Co-Founder and Managing Partner).
SCVC is a venture capital firm specializing in early-stage Deep Tech investments across the UK, operating as the official venture arm of Science Creates. It provides critical funding and strategic guidance to startups leveraging advanced scientific and engineering breakthroughs, particularly in biotech and quantum technologies. The firm's investment strategy focuses on enabling companies with significant intellectual property to scale.
Founded in 2020 by Harry Destecroix, SCVC emerged from the insight that a founder-led venture vehicle could uniquely support the innovative ecosystem fostered by Science Creates. Destecroix, an experienced founder with deep technical expertise, established the firm to deliver tailored investment and mentorship for nascent Deep Tech companies, bridging the gap between scientific discovery and commercial viability.
SCVC primarily supports ambitious early-stage Deep Tech startups within the UK, offering essential capital and expert resources to translate scientific discoveries into commercial successes. The firm's vision centers on cultivating category-defining companies that contribute meaningfully to global health and environmental well-being, leveraging the robust scientific talent originating from UK institutions and incubators.
SCVC has 3 tracked investments across 3 companies. The latest tracked deal is $2.0M Seed in Theo Ai in November 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2024 | Theo Ai | $2.0M Seed | NextView Ventures, Daniel Borok | 186 Ventures, Accomplice VC, Arrive, Baseline Ventures, Beat Ventures, Boston Seed Capital, Collide Capital, Founder Collective, Impellent Ventures, NextGen Venture Partners, Operator Collective, Predictive VC, The HIT Forge, Village Global, VitalStage Ventures, Y Combinator, Akash Garg, Cory Levy, David Chang, Jeff Seibert, Jennifer LUM, Sahin Boydas, Scott Belsky, Wayne Chang, Dominic LAU |
| Nov 9, 2020 | Inmagene Biopharmaceuticals | $21.0M Series B | — | Kunlun Capital |
| Jun 5, 2019 | EpimAb Biotherapeutics | $74.0M Series B | Dongfang LI, Cheng Xing | — |
SCVC was founded in 2020 by Harry Destecroix (Co-Founder and Managing Partner).
Key people at SCVC.